Paradeep Phosphates Limited
NSE:PARADEEP.NS
110.67 (INR) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 38,438.4 | 23,774.3 | 22,427.4 | 25,950.3 | 36,830.2 | 30,543.3 | 36,439.4 | 43,984.3 | 28,636.9 | 24,346.6 | 5,306.88 | 27,093.2 | 19,346.6 | 13,159.9 | 15,542 | 11,411.8 | 10,464 |
| Cost of Revenue
| 29,495.8 | 18,411.5 | 16,496.3 | 18,709.8 | 29,065.2 | 25,715.2 | 29,838 | 35,027.2 | 21,960 | 19,306.6 | 7,972.09 | 22,462.2 | 14,478.1 | 10,093.1 | 12,899.8 | 8,454.1 | 7,756.6 |
| Gross Profit
| 8,942.6 | 5,362.8 | 5,931.1 | 7,240.5 | 7,765 | 4,828.1 | 6,601.4 | 8,957.1 | 6,676.9 | 5,040 | -2,665.21 | 4,631 | 4,868.5 | 3,066.8 | 2,642.2 | 2,957.7 | 2,707.4 |
| Gross Profit Ratio
| 0.233 | 0.226 | 0.264 | 0.279 | 0.211 | 0.158 | 0.181 | 0.204 | 0.233 | 0.207 | -0.502 | 0.171 | 0.252 | 0.233 | 0.17 | 0.259 | 0.259 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 11.819 | 0 | 0 | 0 | 8.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 5,042.697 | 0 | 0 | 0 | 1,894.848 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 106.003 | 0 | 0 | 0 | 8.352 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5,315 | 4,354.4 | 3,871.4 | 3,857 | 4,626.9 | 582.4 | 5,148.7 | 4,663.2 | 4,305 | 3,016.6 | 1,903.2 | 347.4 | 357.3 | 299.1 | 364.4 | 1,020.7 | 1,056.6 |
| Other Expenses
| 0 | 192.1 | 300.3 | 86.4 | 109.9 | 191.8 | 696.8 | 55.4 | 61.2 | 97.3 | 155.16 | 63.4 | 29.5 | 44.3 | 0 | 0 | 0 |
| Operating Expenses
| 5,315 | 4,354.4 | 5,028.3 | 4,967.2 | 5,711.8 | 5,685.9 | 6,200 | 5,710.4 | 5,330.7 | 3,775.9 | -3,514.7 | 2,778.7 | 2,413.5 | 2,257.7 | 2,081.1 | 1,886 | 1,939.6 |
| Operating Income
| 3,627.6 | 1,008.4 | 1,215.1 | 2,359.7 | 2,163.1 | -664 | 1,103.3 | 3,297.2 | 1,411 | 1,264.1 | 1,004.59 | 1,914.45 | 2,487.8 | 857.6 | 560.1 | 1,071.7 | 767.8 |
| Operating Income Ratio
| 0.094 | 0.042 | 0.054 | 0.091 | 0.059 | -0.022 | 0.03 | 0.075 | 0.049 | 0.052 | 0.189 | 0.071 | 0.129 | 0.065 | 0.036 | 0.094 | 0.073 |
| Total Other Income Expenses Net
| -669.6 | -866.8 | -1,472.461 | -738.2 | -849.5 | -737.1 | -797.6 | -823 | -662.6 | -415.4 | -483.79 | -151.6 | -113 | -22.7 | -1,984.2 | -310.5 | -1,442.3 |
| Income Before Tax
| 2,958 | 141.6 | 262.4 | 1,535.1 | 1,203.7 | -1,592.9 | 305.7 | 2,423.7 | 683.6 | 848.7 | 1,532.71 | 1,700.7 | 2,342 | 786.4 | 293.6 | 761.2 | 208.5 |
| Income Before Tax Ratio
| 0.077 | 0.006 | 0.012 | 0.059 | 0.033 | -0.052 | 0.008 | 0.055 | 0.024 | 0.035 | 0.289 | 0.063 | 0.121 | 0.06 | 0.019 | 0.067 | 0.02 |
| Income Tax Expense
| 683.4 | 78.3 | 47.4 | 445.9 | 309.4 | -393.5 | 205.9 | 620.4 | 172.6 | 221 | 164.2 | 423.9 | 590.1 | 187.2 | 216.8 | 260.9 | 67.6 |
| Net Income
| 2,276.3 | 53.8 | 215 | 1,089.2 | 894.3 | -1,199.4 | 99.8 | 1,803.3 | 511 | 627.7 | 1,368.51 | 1,276.8 | 1,751.9 | 599.2 | 76.8 | 500.3 | 140.9 |
| Net Income Ratio
| 0.059 | 0.002 | 0.01 | 0.042 | 0.024 | -0.039 | 0.003 | 0.041 | 0.018 | 0.026 | 0.258 | 0.047 | 0.091 | 0.046 | 0.005 | 0.044 | 0.013 |
| EPS
| 2.79 | 0.066 | 0.26 | 1.34 | 1.1 | -1.47 | 0.12 | 2.21 | 0.63 | 0.93 | 2.42 | 2.22 | 2.15 | 0.74 | 0.14 | 0.87 | 0.24 |
| EPS Diluted
| 2.79 | 0.066 | 0.26 | 1.34 | 1.1 | -1.47 | 0.12 | 2.21 | 0.63 | 0.93 | 2.38 | 2.22 | 2.15 | 0.74 | 0.14 | 0.87 | 0.24 |
| EBITDA
| 4,403 | 1,662.8 | 1,781.2 | 2,911.3 | 2,669.9 | -193.8 | 1,602.9 | 3,772.9 | 1,875.1 | 1,669.7 | 1,179.3 | 2,146.2 | 2,712.8 | 1,071.7 | 767.583 | 1,273 | 943.2 |
| EBITDA Ratio
| 0.115 | 0.068 | 0.08 | 0.112 | 0.072 | -0.007 | 0.044 | 0.086 | 0.066 | 0.069 | 0.233 | 0.079 | 0.14 | 0.081 | 0.049 | 0.112 | 0.09 |